- Question from Steph: Why is there less research out there about hormone-receptor-negative breast cancer?
- Answers - Jennifer Armstrong, M.D. Simply because it's less common.
- Kathy D. Miller, M.D. I'm not sure there's less research about hormone-receptor-negative cancer, but you have to remember that we can't design a therapy to target a negative, or something that is missing in the cancer. So much of the research has focused on trying to identify what does drive the growth of those hormone-receptor-negative cancers, and then developing a therapy to target those factors. That research is just now developing into therapies that are in clinical trials.
On Wednesday, November 19, 2005, our Ask-the-Expert Online Conference was called Hormone-Receptor-Negative Breast Cancer. Kathy D. Miller, M.D., Marisa Weiss, M.D., and moderator Jennifer Armstrong, M.D. answered your questions about a wide range of issues related to hormone-receptor-negative breast cancer.
The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.
A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.